Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
27,691,200
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
9,432,851
-
Shares change
-
+41,581
-
Total reported value, excl. options
-
$77,354,034
-
Value change
-
-$274,816
-
Number of buys
-
19
-
Number of sells
-
-11
-
Price
-
$8.20
Significant Holders of FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) as of Q3 2018
45 filings reported holding FENC - FENNEC PHARMACEUTICALS INC. - Common Shares as of Q3 2018.
FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9,432,851 shares
of 27,691,200 outstanding shares and own 34% of the company stock.
Largest 10 shareholders include Southpoint Capital Advisors LP (3,997,214 shares), venBio Select Advisor LLC (1,022,666 shares), Opaleye Management Inc. (975,000 shares), 683 Capital Management, LLC (971,351 shares), EVENTIDE ASSET MANAGEMENT, LLC (741,175 shares), BlackRock Inc. (559,787 shares), PUTNAM INVESTMENTS LLC (262,033 shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (223,123 shares), STATE STREET CORP (155,725 shares), and NORTHERN TRUST CORP (102,085 shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.